Filtered By:
Cancer: Skin Cancer
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 467 results found since Jan 2013.
Narrative Matters: On Our Reading List
Editor’s note: “Narrative Matters: On Our Reading List” is a monthly roundup where we share some of the most compelling health care narratives driving the news and conversation in recent weeks.
In this month’s Narrative Matters essay, former Department of Health and Human Services (HHS) Secretary Louis Sullivan writes about growing up in rural Georgia and entering medical school as the only black student in his class. Sullivan graduated from Boston University School of Medicine in 1958 with only $500 in debt — hard to fathom when, today, med students might finish school owing some $150,000 to $250,000. Sulli...
Source: Health Affairs Blog - August 12, 2016 Category: Health Management Authors: Jessica Bylander Tags: Elsewhere@ Health Affairs Featured Narrative Matters On Our Reading List opioids Veterans Source Type: blogs
This oncologist says the USPSTF gets it wrong on skin cancer screening
In July 2016, the U.S. Preventative Services Task Force (USPSTF) published updated skin cancer screening guidelines in JAMA, concluding “current evidence is insufficient” to screen for skin cancer in adults. The guidelines were formulated on a literature review of studies conducted in asymptomatic patients 15 years and older at general risk for skin cancer from 1995-2015; after identifying nearly 13,000 articles spanning two decades of work worldwide, the authors selected 13 studies to answer specified “key questions,” such as whether direct evidence exists that skin cancer screening reduces morbidity and mortality...
Source: Kevin, M.D. - Medical Weblog - August 9, 2016 Category: Journals (General) Authors: < a href="http://www.kevinmd.com/blog/post-author/morganna-freeman" rel="tag" > Morganna Freeman, DO < /a > Tags: Physician Cancer Dermatology Source Type: blogs
Striving For Equity In Access To And Use Of Specialty Care
In 2015 the Bristol-Myers Squibb Foundation launched a grant-making initiative called Specialty Care for Vulnerable Populations to address inequities in access to, and utilization of, specialty care services in the United States.
The goal of this national initiative is to catalyze sustainable improvement and expansion of specialty care service delivery by safety-net providers, so as to achieve optimal and more equitable outcomes for the people they serve who are living with complex diseases such as cancers, cardiovascular diseases, and HIV/AIDS. Funding and partnerships focus on efforts to complete systems of care through ...
Source: Health Affairs Blog - August 1, 2016 Category: Health Management Authors: Patricia Mae Doykos Tags: Costs and Spending Drugs and Medical Technology Equity and Disparities GrantWatch Organization and Delivery Population Health Quality Access cancer care Health Care Costs Health Care Delivery health care equity Health Philanthropy Source Type: blogs
Fight Aging! Newsletter, July 18th 2016
In this study, a PET camera was used to examine individual differences in the D2 system in a group consisting of 181 healthy individuals between the age of 64 and 68. All participants also had to take part in an all-inclusive performance test of the long-term episodic memory, working memory and processing speed along with an MRI assessment (which was used to measure the size of various parts of the brain). Researchers could see that the D2 system was positively linked to episodic memory, but not to working memory or to processing speed by relating PET registrations to the cognitive data. Researchers could also see that the...
Source: Fight Aging! - July 17, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Human Telomere Dynamics and the Balance Between Cancer and Atherosclerosis
Today I'll point out a great open access paper on the evolution of human telomere dynamics: telomere length, how that length changes over time, and especially how it changes with aging. This makes a good companion piece to another paper from last week that covered the differences in telomere dynamics between mice and humans. This is quite important, since most of the work on this topic involves mouse studies, not human studies. As telomerase gene therapies continue to extend average telomere length and - in mice at least - also extend healthy life span, this is becoming a hot topic in the aging research community. It is in...
Source: Fight Aging! - July 14, 2016 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Can Coca Cola give you a better sun tan? Episode 141
Can Coca Cola give you a better tan?
Nanda asks…Will Coca Cola give you a better sun tan?
When I first head this I thought it was an obscure, ridiculous rumor. But I was wrong. it turns out it’s a very pervasive, ridiculous rumor.
Yeah, if you Google “using coca cola to tan” you get THOUSANDS of search results from people raving about the tanning powers of Coke. People all over the world say that you can get a darker tan if you apply Coke to your skin. My favorite is…Top ten myths about Coca Cola which just happen to be true. But all the article does is repeat the myth – there’s not a hint of evide...
Source: thebeautybrains.com - July 12, 2016 Category: Consumer Health News Authors: Randy Schueller Tags: Podcast Source Type: blogs
Skin Cancer Prevention Resources from CDC
The Center for Disease Control has numerous shareable skin cancer prevention tools. The Sun Safety Tips for Men page has informational buttons to add to your website. The Skin Cancer Awareness page has infographics, fact sheets, a quiz and posters.
Sun Safety Tips for Men: http://1.usa.gov/1tlP1DV
Skin Cancer Awareness: http://1.usa.gov/1UpWcoO
Source: BHIC - June 13, 2016 Category: Databases & Libraries Authors: Kate Flewelling Tags: Emergency Preparedness Public Health Source Type: blogs
Nanoparticles and RNA Used to Engineer an Immune Response to Cancer
An approach using nanoparticles to deliver RNA to immune cells, so as to kick off an immune response targeted to a specific cancer, has been in the news of late. Immunotherapies of a wide variety of types will form the basis for the coming generation of cancer therapies, the replacements for the present staples of chemotherapy and radiotherapy, but there is far too much work taking place to comment on every single project. It is a matter of accident rather than merit as to which research results receive greater or lesser attention from the public and the media. With the immune system being as complicated as it is, there ar...
Source: Fight Aging! - June 2, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
Fight Aging! Newsletter, May 30th 2016
This study expands on the idea that loss of Y, already a known risk factor for cancer, could be a predictive biomarker for a wider range of poor health outcomes, specifically Alzheimer's. Why loss of Y can be linked to an increased risk for disease remains unclear, but the authors speculate it has to do with reduced immune system performance.
The researchers looked at over 3,000 men to ascertain whether there was any predictive association between loss of Y in blood cells and Alzheimer's disease. The participants came from three long-term studies that could provide regular blood samples: the European Alzheimer's Dis...
Source: Fight Aging! - May 29, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
Borrowed Immune Cells to Fight Cancer
It is an unfortunate fact of life that many promising avenues of medical research languish partially developed and unfunded. It isn't unusual to see potentially transformative medical technologies linger with little further progress for a decade or more after their first triumphant discovery. The innovative antiviral DRACO technology is one such, offering the potential of therapies for persistent infections that cannot currently be treated. Another is the use of immune cell transplants to attack cancer, presented in its initial form of granulocyte infusion therapy (GIFT) with accompanying compelling animal data at the thir...
Source: Fight Aging! - May 27, 2016 Category: Research Authors: Reason Tags: Medicine, Biotech, Research Source Type: blogs
Sharing My Skin Cancer Story
Telling people about my cancer diagnosis was not easy to do. At the time of my diagnosis, we were in a different world than we are today. I had some skin cancers that came up on the top of my forehead. I didn’t tell anyone about it. I didn’t tell family, parents, anybody else. I was a sophomore at the University of Texas playing golf. I didn’t talk to anybody because I was afraid I would lose my scholarship. I was afraid I would lose my opportunity to compete.
I realize now that not sharing my story was the wrong decision because I could have gotten so much more help and more support. It was probably more...
Source: LIVESTRONG Blog - May 26, 2016 Category: Cancer & Oncology Authors: Greg Lee, President Source Type: blogs
To my fellow school of medicine graduates: Give it to them straight
I would have graduated from medical school this year. That’s right. Just like you, I’d be getting ready to move to another city and take up residence at an academic medical center to begin my clinical training. Things don’t always work out the way we planned: like Lenny and George in Steinbeck’s, Of Mice and Men. Sometimes, the best-laid plans have a way of going awry no matter how carefully we prepare them.
Cancer. I wasn’t worried. It was just a little mole. Melanoma. Only a few microscopic cells hiding in my lymph nodes. If I was older, I might be concerned. Interferon alpha (a) was the ...
Source: Kevin, M.D. - Medical Weblog - May 23, 2016 Category: Journals (General) Authors: Linda Haller Tags: Patient Cancer Source Type: blogs
4 Encouraging Advances in Ovarian Cancer Research
It’s estimated that in 2016, more than 22,000 women in the U.S. will be diagnosed with ovarian cancer. While the prevalence of this disease is relatively low, most diagnoses are made in the later stages, when women face a lower chance of survival.
Early detection has become a primary focus in ovarian cancer research. And the progress in research and testing means there are more long-term survivors than ever before.
Knowledge of the disease’s symptoms and the importance of care by a gynecologic oncologist can have a positive impact. As new advances are made, it’s more important than ever for women to be educated about...
Source: Disruptive Women in Health Care - April 8, 2016 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Cancer Source Type: blogs
Blocking the escape routes
How an HIV drug exposes skin cancer’s weaknesses Related items from OnMedicaNICE approves skin cancer drug in final draft guidanceUN achieves HIV treatment target 9 months earlyGreen light for new drug for advanced skin cancerImmunotherapy drug combo curbs melanoma advancePlans for PrEP treatment for HIV dropped
Source: OnMedica Blogs - March 22, 2016 Category: Journals (General) Source Type: blogs
Cancer and Moonshot Economics
By STEVE FINDLAY
The Obama Administration’s cancer “moonshot” initiative, announced in January and now being debated in Congress, comes at a time of significant advances in cancer treatment and a spurt of cultural attention to the disease.
A batch of new immunotherapy drugs approved in the last few years, such as Bristol-Myers Squibb’s Opdivo and Merck’s Keytruda, are being widely touted as breakthrough medicines—and aggressively advertised to both doctors and the public. Jimmy Carter’s unexpected remission from melanoma that had spread to his liver and brain is attributed to Keytruda.
At the same time, a ...
Source: The Health Care Blog - March 11, 2016 Category: Consumer Health News Authors: Simon Nath Tags: THCB Precision Medicine Initiative Source Type: blogs
